D’Arcy, Monica
Fleming, Jodie
Robinson, Whitney R.
Kirk, Erin L.
Perou, Charles M.
Troester, Melissa A.
Funding for this research was provided by:
National Institutes of Health (5 R25 CA057726-23, R21 CA175783, U01 CA 179715, U01 ES 019472, P50 CA058223, R21 CA175783, U54 CA156735, U54 CA156735, K01CA172717)
Article History
Received: 2 March 2015
Accepted: 15 June 2015
First Online: 25 June 2015
Compliance with ethical standard
:
: C.M.P is an equity stock holder, and Board of Director Member, of BioClassifier LLC and GeneCentric Diagnostics. C.M.P is also listed an inventor on a patent application for the PAM50 assay.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.